title: Can stem blood cell transplantation be an adjuvant treatment for primary cardiac lymphoma?
authors.forename: Reinaldo B
authors.initials: RB
authors.lastname: Bestetti
authors.forename: Carlos E
authors.initials: CE
authors.lastname: Miguel
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006338:Heart Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000000981:diagnostic imaging / Q000628:therapy*; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D011241:Prednisone / Q000008:administration & dosage; D011859:Radiography; D000069283:Rituximab; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone